Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Long Term Psycho-Social Aspects and Risk Factors for Severe Infections, Ocular, Pulmonary, Bone, Thyroid and Other Complications after Allogeneic Hematopoietic Stem Cell Transplantation for Children with Hematologic Malignancies.

Christèle Ferry, MD, Gladys Gemayel, MD, Vanderson Rocha, MD PHD, Myriam Labopin, MD, Hélène Esperou, MD, Marie Robin, MD, Régis Peffault de Latour, MD, Patricia Ribaud, MD, Agnès Devergie, MD, Eliane Gluckman, MD PHD, Gerard Socie, MD PHD

Blood (2006) 108 (11): 3371.

https://doi.org/10.1182/blood.V108.11.3371.3371

Published: 2006

Journal Articles

A New Busulfan Fixed Dosing for Conditioning before Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children with Malignant and Non-Malignant Diseases: Pharmacokinetics, Toxicity and Clinical Outcomes.

Gérard Michel, MD, Dominique Valteau-Couanet, MD, Hélène Esperou, MD, Jean Claude Gentet, MD, François Doz, MD, Françoise Méchinaud, MD, Claire Galambrun, MD, Alain Fischer, MD, Hamadi Zouabi, MD, Christian Puozzo, PhD, Gilles Vassal, MD, PhD

Blood (2005) 106 (11): 1758.

https://doi.org/10.1182/blood.V106.11.1758.1758

Published: 2005

Journal Articles

A New IV Busulfan Fixed Dosing as Part of BuMel or BuCy Conditioning Regimens: A Pharmacokinetic/Pharmacodynamic Study in Pediatric Patients Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Gilles Vassal, MD, PhD, Hélène Esperou, MD, Dominique Valteau-Couanet, MD, Jean Claude Gentet, MD, François Doz, MD, Françoise Méchinaud, MD, Claire Galambrun, MD, Alain Fischer, MD, Hamadi Zouabi, MD, Laurent Nguyen, Pharm D, Gérard Michel, MD

Blood (2005) 106 (11): 5200.

https://doi.org/10.1182/blood.V106.11.5200.5200

Published: 2005

Journal Articles

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Thomas Prebet, MD, Quoc-Hung Le, MD, Jean-Michel Boiron, MD, Didier Blaise, MD, Anne Huynh, MD, Ibrahim Yakoub-Agha, MD, Hélène Esperou, MD, Fréderic Garban, MD, PhD, Jean Henri Bourhis, MD, Mauricette Michallet, MD, PhD

Blood (2005) 106 (11): 1146.

https://doi.org/10.1182/blood.V106.11.1146.1146

Published: 2005

Journal Articles

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Le, MD, Thomas Prebet, MD, Mohamad Mohty, MD, PhD, Jean Michel Boiron, MD, Hélène Esperou, MD, Noel Milpied, MD, Nathalie Dhédin, MD, Didier Blaise, MD

Blood (2005) 106 (11): 45.

https://doi.org/10.1182/blood.V106.11.45.45

Published: 2005

NARROW

Long Term Psycho-Social Aspects and Risk Factors for Severe Infections, Ocular, Pulmonary, Bone, Thyroid and Other Complications after Allogeneic Hematopoietic Stem Cell Transplantation for Children with Hematologic Malignancies.

A New Busulfan Fixed Dosing for Conditioning before Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children with Malignant and Non-Malignant Diseases: Pharmacokinetics, Toxicity and Clinical Outcomes.

A New IV Busulfan Fixed Dosing as Part of BuMel or BuCy Conditioning Regimens: A Pharmacokinetic/Pharmacodynamic Study in Pediatric Patients Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Email alerts

ASH Publications

American Society of Hematology

Long Term Psycho-Social Aspects and Risk Factors for Severe Infections, Ocular, Pulmonary, Bone, Thyroid and Other Complications after Allogeneic Hematopoietic Stem Cell Transplantation for Children with Hematologic Malignancies.

A New Busulfan Fixed Dosing for Conditioning before Autologous or Allogeneic Hematopoietic Stem Cell Transplantation in Children with Malignant and Non-Malignant Diseases: Pharmacokinetics, Toxicity and Clinical Outcomes.

A New IV Busulfan Fixed Dosing as Part of BuMel or BuCy Conditioning Regimens: A Pharmacokinetic/Pharmacodynamic Study in Pediatric Patients Undergoing Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Impact of Hematopoietic Stem Cell (HSC) Recruitment and Graft Composition on Transplant Outcome after Reduced Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): A Study of the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Updated Analysis of Hematopoietic Stem Cell Transplantations after Reduced Intensity Conditioning Regimen (RIC HSCT) for Hematological Malignancies from the Société Française de Greffe de Moelle Osseuse et de Thérapie Cellulaire (SFGM-TC) Registry.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only